Formulation Development of SYN-004 (ribaxamase) Oral Solid...

  • Main
  • 2017 / 10
  • Formulation Development of SYN-004 (ribaxamase) Oral Solid...
International Journal of Pharmaceutics 2017 / 10

Formulation Development of SYN-004 (ribaxamase) Oral Solid Dosage Form, a β-Lactamase to Prevent Intravenous Antibiotic-Associated Dysbiosis of the Colon

Bristol, Andrew, Hubert, Steven, Hofmann, Felix, Baer, Hans
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
International Journal of Pharmaceutics
DOI:
10.1016/j.ijpharm.2017.10.001
Date:
October, 2017
File:
PDF, 811 KB
english, 2017
Conversion to is in progress
Conversion to is failed